Neogenomics (NEO) Cash & Equivalents Growth (1y) (2011 - 2026)
Neogenomics (NEO) Cash & Equivalents Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | 20.63% |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | -21.29% |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | 186.05% |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 22.30% |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 21.60% |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | 11.90% |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | 12.96% |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | -2.16% |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | -5.74% |
| 10 | Neogenomics | 1.46 Bn | 1.32 Bn | 80.86 Mn | -57.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -57.79% |
| Dec 31, 2025 | -56.51% |
| Sep 30, 2025 | -54.66% |
| Jun 30, 2025 | -56.43% |
| Mar 31, 2025 | 4.30% |
| Dec 31, 2024 | 7.16% |
| Sep 30, 2024 | 18.21% |
| Jun 30, 2024 | 22.84% |
| Mar 31, 2024 | 20.43% |
| Dec 31, 2023 | 30.13% |
| Sep 30, 2023 | 15.07% |
| Jun 30, 2023 | 1.92% |
| Mar 31, 2023 | -9.90% |
| Dec 31, 2022 | -16.93% |
| Sep 30, 2022 | -21.86% |
| Jun 30, 2022 | -23.09% |
| Mar 31, 2022 | -50.01% |
| Dec 31, 2021 | 38.53% |
| Sep 30, 2021 | 46.02% |
| Jun 30, 2021 | 24.90% |